{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:38:07Z","timestamp":1788028687165,"version":"build-2784847793"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"CombinatoRx, Incorporated"},{"name":"National Multiple Sclerosis Society Postdoctoral Fellowship","award":["FG-1667A1\/2"],"award-info":[{"award-number":["FG-1667A1\/2"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1016\/j.cellimm.2011.05.015","type":"journal-article","created":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T14:41:53Z","timestamp":1307284913000},"page":"237-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Combination treatment of mice with crx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"270","author":[{"given":"Joseph R.","family":"Podojil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh V.","family":"Padval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2011.05.015_b0005","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0167-5699(89)90236-3","article-title":"MS: a CNS and systemic autoimmune disease","volume":"10","author":"Hafler","year":"1989","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cellimm.2011.05.015_b0010","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1172\/JCI114800","article-title":"Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma","volume":"86","author":"Olsson","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2011.05.015_b0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/jaut.1999.0321","article-title":"Multiple sclerosis and central nervous system demyelination","volume":"13","author":"Pouly","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2011.05.015_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-5728(91)90034-5","article-title":"Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides","volume":"33","author":"Trotter","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.neuro.25.112701.142913","article-title":"Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy","volume":"25","author":"Steinman","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.cellimm.2011.05.015_b0030","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1084\/jem.170.5.1671","article-title":"Engagement of CD4 and CD8 expressed on immature thymocytes induces activation of intracellular tyrosine phosphorylation pathways","volume":"170","author":"Veillette","year":"1989","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2011.05.015_b0035","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1073\/pnas.88.6.2466","article-title":"Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals","volume":"88","author":"Ben-Nun","year":"1991","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2011.05.015_b0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-5728(91)90177-9","article-title":"Autoantigen-induced self lysis of human myelin basic protein-specific T lymphocytes","volume":"35","author":"Burns","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0045","first-page":"69","article-title":"Encephalomyelitis of mice. II a method for the measurement of virus activity","volume":"72","author":"Theiler","year":"1940","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2011.05.015_b0050","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-3083.1993.tb02565.x","article-title":"T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis","volume":"37","author":"Soderstrom","year":"1993","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0055","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.4049\/jimmunol.146.5.1490","article-title":"T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis","volume":"146","author":"Sun","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1212\/WNL.43.2.403","article-title":"The T-lymphocyte response against myelin-associated glycoprotein and myelin basic protein in patients with multiple sclerosis","volume":"43","author":"Zhang","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.cellimm.2011.05.015_b0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0070","series-title":"Immunological Diseases","first-page":"1877","article-title":"Demyelinating diseases of the central and peripheral nervous systems","author":"Paterson","year":"1998"},{"key":"10.1016\/j.cellimm.2011.05.015_b0075","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4049\/jimmunol.164.2.670","article-title":"Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis","volume":"164","author":"Vanderlugt","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0080","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0952-7915(96)80012-4","article-title":"Epitope spreading","volume":"8","author":"Vanderlugt","year":"1996","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0085","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0014-2999(72)90192-6","article-title":"Pharmacologic blockade of reflex vasodilation: peripheral actions of antihistamines","volume":"20","author":"Boerth","year":"1972","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0090","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1365-2222.2008.02990.x","article-title":"Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms","volume":"38","author":"Roumestan","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.cellimm.2011.05.015_b0095","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1172\/JCI32792","article-title":"Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice","volume":"117","author":"Noubade","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2011.05.015_b0100","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1073\/pnas.252777399","article-title":"Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination","volume":"100","author":"Pedotti","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cellimm.2011.05.015_b0105","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.4049\/jimmunol.180.11.7471","article-title":"Autoimmune disease-associated histamine receptor H1 alleles exhibit differential protein trafficking and cell surface expression","volume":"180","author":"Noubade","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0008-8749(87)90124-9","article-title":"Differential susceptibility to actively induced experimental allergic encephalomyelitis and experimental allergic orchitis among BALB\/c substrains","volume":"110","author":"Teuscher","year":"1987","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000093709","article-title":"Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: implications for anti-inflammatory activity of antihistamines","volume":"140","author":"Traidl-Hoffmann","year":"2006","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1471-4906(01)01862-2","article-title":"Bypassing IgE and targeting T cells for specific immunotherapy of allergy","volume":"22","author":"Akdis","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2249.2009.03958.x","article-title":"Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)\/Th2 cytokine imbalance and inflammatory responses in allergic diseases","volume":"157","author":"Okamoto","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0130","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00001756-200208070-00012","article-title":"Activation of histamine H2 receptors ameliorates experimental allergic encephalomyelitis","volume":"13","author":"Emerson","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.cellimm.2011.05.015_b0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0002-9440(10)63176-8","article-title":"Attenuation of Th1 effector cell responses and susceptibility to experimental allergic encephalomyelitis in histamine H2 receptor knockout mice is due to dysregulation of cytokine production by antigen-presenting cells","volume":"164","author":"Teuscher","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0140","first-page":"1165","article-title":"Histamine and asthma","volume":"135","author":"White","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.cellimm.2011.05.015_b0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0006-3223(91)90297-Y","article-title":"Nortriptyline in chronic fatigue syndrome: a double blind, placebo-controlled single case study.","volume":"30","author":"Gracious","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.cellimm.2011.05.015_b0150","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/00007611-199709000-00003","article-title":"Diagnosis, prophylaxis, and treatment of headaches in the athlete.","volume":"90","author":"Swain","year":"1997","journal-title":"South Med. J."},{"key":"10.1016\/j.cellimm.2011.05.015_b0155","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(09)61205-8","article-title":"Neuropathic pain treatment: a further step forward","volume":"374","author":"Jensen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cellimm.2011.05.015_b0160","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-4295(79)90512-0","article-title":"Uropharmacology: XII miscellaneous drugs affecting lower urinary tract","volume":"14","author":"Bissada","year":"1979","journal-title":"Urology"},{"key":"10.1016\/j.cellimm.2011.05.015_b0165","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.4049\/jimmunol.158.9.4200","article-title":"Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help","volume":"158","author":"Sanders","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4049\/jimmunol.166.1.232","article-title":"IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine","volume":"166","author":"Swanson","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0167-5699(00)01747-3","article-title":"Norepinephrine: a messenger from the brain to the immune system","volume":"21","author":"Kohm","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.cellimm.2011.05.015_b0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1006\/cimm.1994.1261","article-title":"Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells","volume":"158","author":"Bartik","year":"1994","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0185","first-page":"395","article-title":"Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin","volume":"80","author":"Young","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2011.05.015_b0190","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.153.2.489","article-title":"Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo","volume":"153","author":"Aune","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.euroneuro.2005.11.011","article-title":"Antidepressants suppress production of the Th1 cytokine interferon-gamma,independent of monoamine transporter blockade","volume":"16","author":"Diamond","year":"2006","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0200","first-page":"105","article-title":"Clinical aspects of serotonin therapy of autoimmune disturbances","volume":"10","author":"Abramchik","year":"1984","journal-title":"Hum. Physiol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nm1202","article-title":"Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis","volume":"11","author":"McMahon","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2011.05.015_b0210","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.4049\/jimmunol.168.8.4173","article-title":"De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis","volume":"168","author":"Tompkins","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0215","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1177\/0091270004269518","article-title":"Pharmacokinetics\/pharmacodynamics of desloratadine and fluoxetine in healthy volunteers","volume":"44","author":"Gupta","year":"2004","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0220","first-page":"72P","article-title":"Histamine in tissue mast cells","volume":"117","author":"Riley","year":"1952","journal-title":"J. Physiol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0225","first-page":"44P","article-title":"Mast cells and histamine in normal and pathological tissues","volume":"119","author":"Riley","year":"1953","journal-title":"J. Physiol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00011-003-1227-z","article-title":"Regulation of Con A-dependent cytokine production from CD4+ and CD8+ T lymphocytes by autosecretion of histamine","volume":"53","author":"Sonobe","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cellimm.2011.05.015_b0235","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2222.2007.02904.x","article-title":"Medication with antihistamines impairs allergen-specific immunotherapy in mice","volume":"38","author":"Johansen","year":"2008","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.cellimm.2011.05.015_b0240","first-page":"203","article-title":"Distinct effects of sphingosine-1-phosphate lysophosphatidic acid and histamine in human and mouse dendritic cells","volume":"13","author":"Renkl","year":"2004","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cellimm.2011.05.015_b0245","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.4049\/jimmunol.179.6.3425","article-title":"Histamine improves antigen uptake and cross-presentation by dendritic cells","volume":"179","author":"Amaral","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0250","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.4049\/jimmunol.166.6.3789","article-title":"IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo","volume":"166","author":"Hara","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0255","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.20042398","article-title":"Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes","volume":"201","author":"Pop","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2011.05.015_b0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri1032","article-title":"Natural versus adaptive regulatory T cells","volume":"3","author":"Bluestone","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0265","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.4049\/jimmunol.0802509","article-title":"Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction","volume":"183","author":"Forward","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-2999(80)90006-0","article-title":"High affinity binding of tricyclic antidepressants to histamine H1-receptors: fact and artifact","volume":"67","author":"Taylor","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellimm.2011.05.015_b0275","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/0024-3205(84)90441-7","article-title":"Tricyclic antidepressant drugs affect histamine receptors in human leukocytes","volume":"35","author":"Sadava","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.cellimm.2011.05.015_b0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/AJP.0b013e318190862b","article-title":"Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation","volume":"25","author":"Chitsaz","year":"2009","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.cellimm.2011.05.015_b0285","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.4049\/jimmunol.159.10.4857","article-title":"Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production","volume":"159","author":"Ramer-Quinn","year":"1997","journal-title":"J. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874911001353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874911001353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:46:39Z","timestamp":1757803599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874911001353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"alternative-id":["S0008874911001353"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2011.05.015","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination treatment of mice with crx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2011.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}